Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9262111 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL866984 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL5188 | 1.00 | — | — | |
| SCHEMBL7589647 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL2081 | 1.00 | — | — | |
| SCHEMBL15121489 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL16694147 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL5429 | 1.00 | — | — | |
| SCHEMBL3030900 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL21831576 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | claimed |
| WO-2023125184-A1 | TERTIARY AMINE LIPID COMPOUND AND USE THEREOF | 华南理工大学 | 2023-07-06 | — | — | WO | claimed |
| EP-2662434-B1 | Use of specific compounds for enhancing odours | SYMRISE AG (DE) | 2018-03-21 | — | — | EP | claimed |
| EP-2522669-B1 | 3-Spirocyclic indolyl derivatives useful as ORL-1 receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2016-12-28 | — | — | EP | claimed |
| EP-2522669-A1 | 3-Spirocyclic indolyl derivatives useful as ORL-1 receptor modulators | Janssen Pharmaceutica NV (BE) | 2012-11-14 | — | — | EP | claimed |
| EP-1890696-A2 | NOVEL 3-SPIROCYCLIC INDOLYL DERIVATIVES USEFUL AS ORL-1 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-02-27 | — | — | EP | claimed |
| US-20070112016-A1 | Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-05-17 | — | — | US | claimed |
| WO-2006130416-A2 | NOVEL 3-SPIROCYCLIC INDOLYL DERIVATIVES USEFUL AS ORL-1 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-12-07 | — | — | WO | claimed |
| EP-0193065-B1 | Morpholine derivatives, processes for their production and their use as fungicides | BASF AG (DE) | 1995-08-23 | — | — | EP | claimed |
| EP-0048376-A1 | Process for the preparation of N-substituted diaryl imidodicarboxylates | BAYER AG (DE) | 1982-03-31 | — | — | EP | claimed |
| CN-117396564-A | non-CR passivating compositions and articles treated therewith | 凯密特尔有限责任公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117355575-A | Aqueous composition for metal surface treatment and application thereof | 凯密特尔有限责任公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | disclosed |
| US-20230233526-A1 | GRANZYME B INHIBITOR COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SKIN BLISTERING AND/OR PEELING | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-07-27 | — | — | US | disclosed |
| WO-2023125184-A1 | TERTIARY AMINE LIPID COMPOUND AND USE THEREOF | 华南理工大学 | 2023-07-06 | — | — | WO | disclosed |
| US-4206076-A | STABILIZERS AGAINST HEAT, LIGHT, OR OXYGEN | SANDOZ LTD. (CH) | 1980-06-03 | — | — | US | disclosed |
| US-4167573-A | Method of controlling fungi with 3,5-dimethyl-piperidin-4-ones | BASF AKTIENGESELLSCHAFT (DE) | 1979-09-11 | — | — | US | disclosed |
| US-4107138-A | Phosphonous and thiophosphonous acid ethers as stabilizers for organic materials | SANDOZ LTD. (CH) | 1978-08-15 | — | — | US | disclosed |
| US-3987097-A | INCREASING AFFINITY FOR ANIONIC DYES | SANDOZ LTD. (CH) | 1976-10-19 | — | — | US | disclosed |
| US-3936479-A | 2-BENZAMIDO-BENZOPHENONES, UV STABILIZERS, PLASTICS | SANDOZ LTD., (SANDOZ AG) (CH) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112016-A1 | Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators | OXER1, OGFRL1, NR1H2 | ALDH1A1 378/4885HSD17B10 1519/4885CES2 3315/4885 |
| US-20230233526-A1 | GRANZYME B INHIBITOR COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SKIN BLISTERING AND/OR PEELING | GZMB, SERPINB1, CTSB | ALDH1A1 4771/4885HSD17B10 3048/4885CES2 3360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.